Health and access to health care is one of the major challenges of the 21st century. In the last decades in many parts of the world, overall health has improved. However, health levels have now stagnated and are even declining due to new forms of poverty, environmental problems, and political instability. This does not only affect populations in the Global South, but also marginalized groups in the industrialized world. The 13th Berlin Roundtables on Transnationality want to investigate fault lines, critical developments, and new chances for today’s global health system. The evening lectures will focus on the role of the pharmaceutical industries and new options for democratic access to necessary medication for the world’s poor.
Thomas Pogge
The Health Impact Fund – A Solution towards Global Health?
Thomas Pogge will delineate the proposal of the Health Impact Fund (HIF) as a new international agency for stimulating research and development of life-saving pharmaceuticals that make substantial reductions in the global burden of disease. The HIF aims at providing pharmaceutical companies with the option of either selling a new medicine in the usual manner at patent-protected high prices or to register their new medicine with the HIF and sell it globally at the cost of production.
Thomas Pogge is the Director of the Global Justice Program and Leitner Professor of Philosophy and International Affairs at Yale University. Among his most recent publications are Politics as Usual: What Lies behind the Pro-Poor Rhetoric (Cambridge: Polity Press, 2010) and The Health Impact Fund: Making New Medicines Accessible for All (authored with Aidan Hollis; http://www.healthimpactfund.org, 2008).
Frank Gotthardt
Fighting Schistosomiasis – The Praziquantel Donation Project
Schistosomiasis, which is triggered by worms and primarily affects children, is the second-most common tropical disease in Africa. It causes anaemia, stunted growth and leads to learning disabilities. 90 percent of those affected live in sub-Saharan Africa. Every year, around 200,000 people die of the disease. In 2007, Merck entered into a partnership with the WHO to combat the disease primarily in African school-age children. Until 2017, Merck will donate 200 million tablets containing the active ingredient praziquantel that will permit the treatment of 27 million children.
Frank Gotthardt is head of Public Affairs of the global pharmaceutical company Merck. He is in charge of the Corporate Responsibility Activities, including the Merck-Praziquantel Donation Program. Before joining Merck in 2009, Gotthardt was a Member of Parliament in Hessen, where he also served as State Secretary in the Ministry for Environment (2001-2003).
Lectures will be followed by discussion and a
reception.
All lectures are held in English.
Hinweise zur Teilnahme:
Termin:
03.12.2010 18:00 - 20:00
Veranstaltungsort:
Reichpietschufer 50, Room A 300
10785 Berlin
Berlin
Deutschland
Zielgruppe:
Journalisten, Wissenschaftler
E-Mail-Adresse:
Relevanz:
überregional
Sachgebiete:
Ernährung / Gesundheit / Pflege, Gesellschaft, Politik
Arten:
Eintrag:
12.11.2010
Absender:
Dr. Paul Stoop
Abteilung:
Informations- und Kommunikationsreferat
Veranstaltung ist kostenlos:
nein
Textsprache:
Englisch
URL dieser Veranstaltung: http://idw-online.de/de/event33318
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).